Anicare Pharmaceuticals Pvt Ltd. — Navi Mumbai
USFDA inspection record for FEI 3007450508, Navi Mumbai, India.
OAI
Latest classification
1
Inspections on record
4
Form 483 observations on record
History (newest first)
Inspections
20 Jan 2023
OAI — Official action indicated
Drug Quality Assurance · Drugs · FY2023
Form 483: 4 observations
- Storage under appropriate conditions (21 CFR 211.142(b))
- Mfg / Processing Operations Area (21 CFR 211.42(c)(5))
- Identification of new containers (21 CFR 211.101(b))
- Microbiological testing (21 CFR 211.165(b))
Source: FDA Data Dashboard ↗
📎 Cite this data: Source: PharmaRoz, FDA inspection record for FEI 3007450508, updated 12 Nov 2026